catechol has been researched along with Liver Neoplasms in 3 studies
Liver Neoplasms: Tumors or cancer of the LIVER.
Excerpt | Relevance | Reference |
---|---|---|
"For targeted delivery, hepatocellular carcinoma (HCC)-targeting peptide (SP94, SFSIIHTPILPL) is synthesized and chemically conjugated to the exterior surface of the P22 viral capsid nanocomposites." | 1.40 | Development of P22 viral capsid nanocomposites as anti-cancer drug, bortezomib (BTZ), delivery nanoplatforms. ( Hong, SY; Kang, S; Min, J; Moon, H; Shin, HH; Yang, HJ, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Lim, WC | 1 |
Kim, H | 1 |
Kim, YJ | 1 |
Jeon, BN | 1 |
Kang, HB | 1 |
Ko, H | 1 |
Min, J | 1 |
Moon, H | 1 |
Yang, HJ | 1 |
Shin, HH | 1 |
Hong, SY | 1 |
Kang, S | 1 |
Nakamura, A | 1 |
Shirai, T | 1 |
Takahashi, S | 1 |
Ogawa, K | 1 |
Hirose, M | 1 |
Ito, N | 1 |
3 other studies available for catechol and Liver Neoplasms
Article | Year |
---|---|
Catechol inhibits epidermal growth factor-induced epithelial-to-mesenchymal transition and stem cell-like properties in hepatocellular carcinoma cells.
Topics: Carcinoma, Hepatocellular; Catechols; Cell Line, Tumor; Cell Movement; Cell Proliferation; Enzyme Ac | 2020 |
Development of P22 viral capsid nanocomposites as anti-cancer drug, bortezomib (BTZ), delivery nanoplatforms.
Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Capsid Proteins; Carcinoma, Hepatocellular; Catech | 2014 |
Lack of modification by naturally occurring antioxidants of 3,2'-dimethyl-4-aminobiphenyl-initiated rat prostate carcinogenesis.
Topics: Aminobiphenyl Compounds; Animals; Antioxidants; Carcinogens; Catechols; Hydroquinones; Hyperplasia; | 1991 |